Stereotaxis Stock Price and Value Analysis

Should you buy Stereotaxis stock? (Other OTC:STXS). Let's see how it does in our automated value investing analysis system.

  • This company has stable growth.
  • This company is solid.
  • This stock looks overpriced.
  • This company is not making money.
  • This company pays no dividend.

STXS Free Cash Flow Trend

Hmm, we can't give any reliable projection for Stereotaxis's growth rate. The company either has too few years of historical data for us to examine, or it's in the habit of losing money.

None of this means it's a bad stock. Maybe it's new and growing quickly, or maybe it's turning things around. We can't say anything sensible about it, so we won't say it's obviously undervalued right now. Proceed at your own risk!

Free Cash Flow trendline for STXS
Free Cash Flow trendline for Stereotaxis

Inside the STXS Numbers

STXS Price
(Stereotaxis stock price per share)
[?] PE Ratio versus Sector 17% higher than other Healthcare stocks
[?] PE Ratio versus Industry 45% higher than other Medical Appliances & Equipment stocks
[?] Cash Yield -14.98%
[?] Free Cash Flow Jitter 24%

Is Stereotaxis Stock on Sale?

Based on our analysis, we believe that you should not buy Stereotaxis right now. It might be a good stock to own—we just can't prove it with value analysis right now. Proceed with caution.

Should You Buy STXS Stock?

Does Stereotaxis have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.